News
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.
Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...
A federal bankruptcy court this week approved the sale of 23andMe to TTAM Research Institute - a new company launched by ...
Ford Motor Co. is recalling more than 200,000 vehicles because a software defect can cause the rearview camera to fail, ...
Global News on MSN14d
Health Matters: Wojcicki's nonprofit approved to buy 23andMeAnne Wojcicki's TTAM Research Institute has received court approval to acquire 23andMe, the genetic testing company she co-founded. The $305 million US dollar deal follows 23andMe's Chapter 11 ...
States with privacy objections to the sale have until July 7 to reach a stay to appeal the case. TTAM, a nonprofit started by ...
That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s ...
Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.
A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...
A bankruptcy court gave the green light for TTAM Research Institute - a firm launched by 23andMe's co-founder and former CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results